Sempozyum Videoları

Distant metastases and late local re-growths during W+W: should we be worried? – Philip Paty

What is optimal follow-up plan for W+W – Oktar Asoğlu

Is W+W a standard approach? What do I tell the patient? – Geerard L Beets

Biological therapies for rectal cancer – Gökhan Demir

ISU University/Liv Hospital Experience – Oktar Asoğlu

Enhancing response to radiotherapy for W&W strategy? Rob Glynne – Jones

How long should we wait for obtaining the optimal response? – Cem Terzi

Induction and consolidation chemotherapy in W+W strategy. – Duygu Derin

The Maastricht/Dutch Experience – Geerard L Beets

The MSKCC Experience – Philip Paty

Is W+W an option for more advanced (bulky, cT4, or cN2) rectal cancers?

Are there clinical or molecular predictors of response? Are they helpful?

What is the rol of PET/CT assessing the response to neoadjuvant treatment ? Handan Tokmak

Is pathologic assessment necessary in clinical complete response.

Challenges and limitations of imaging to assess the response to treatment? – Regina Beets

What is the definition of clinical complete response? Why is it important?

The evolving role of MRI in rectal cancer: what have we learned and what is next?

Neoadjuvant therapy and its impact on the radicalism of surgery: past, present, and future.